Tag Archives: Forbes

Forbes: Faster FDA Approvals Have Not Caused More Drug Safety Problems

FDA115x76

In 1992, Congress, industry, and the FDA worked together to create the Prescription Drug User Fee Act (PDUFA). This program ensures that FDA has the ability to hire additional reviewers to expedite the drug review process by having industry pay “user fees.” Recently, attention has been given to a flawed study in the August 2014 issue of Health Affairs, which has some critics claiming that PDUFA fees are biasing FDA review decisions. The study looked at Read More >

Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , ,

What to Wear at the BIO International Convention

Fashion

As a 20-something female, I find waking up in the morning the hardest part of my day because I know I’m going to dig through my closet and try on at least 3 different outfits until I find one that “will do.” With the BIO International Convention sneaking up at the end of June, you might be having a similar problem and asking yourself “What to Wear at the BIO International Convention.” It’s a good Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Forbes: Sure, We’ll (Eventually) Beat Cancer. But Can We Afford To?

Biopharmaceuticals and Accountable Care Organizations: Balancing Cost and Quality

On May 19, Paul Howard highlighted the promise of immunotherapy for the treatment and possible eventual cure of cancer but emphasized that it is critical to focus on the long-term perspective. Key points raised in the article: ‘Reducing incentives for innovation (and drug development returns are roughly comparable to those in the software industry) and you would encourage investors to park more of their capital in more lucrative investments (think: Snapchat), and less into research for Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,